Waldenström macroglobulinemia: A review of therapy

Morie A. Gertz

doi:10.1002/ajh.20363

Waldenström macroglobulinemia: A review of therapy

Morie A. Gertz

Hematology

Research output: Contribution to journal › Review article › peer-review

15 Scopus citations

Abstract

Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

Original language	English (US)
Pages (from-to)	147-157
Number of pages	11
Journal	American journal of hematology
Volume	79
Issue number	2
DOIs	https://doi.org/10.1002/ajh.20363
State	Published - Jun 2005

Keywords

Hyperviscosity syndrome
Lymphoplasmacytic lymphoma
Monoclonal antibody therapy
Monoclonal gammopathy
Waldenström macroglobulinemia

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.20363

Cite this

@article{33c08c488350495eae251da83a13d393,

title = "Waldenstr{\"o}m macroglobulinemia: A review of therapy",

abstract = "Waldenstr{\"o}m macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenstr{\"o}m macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.",

keywords = "Hyperviscosity syndrome, Lymphoplasmacytic lymphoma, Monoclonal antibody therapy, Monoclonal gammopathy, Waldenstr{\"o}m macroglobulinemia",

author = "Gertz, {Morie A.}",

year = "2005",

month = jun,

doi = "10.1002/ajh.20363",

language = "English (US)",

volume = "79",

pages = "147--157",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "2",

}

TY - JOUR

T1 - Waldenström macroglobulinemia

T2 - A review of therapy

AU - Gertz, Morie A.

PY - 2005/6

Y1 - 2005/6

N2 - Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

AB - Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

KW - Hyperviscosity syndrome

KW - Lymphoplasmacytic lymphoma

KW - Monoclonal antibody therapy

KW - Monoclonal gammopathy

KW - Waldenström macroglobulinemia

UR - http://www.scopus.com/inward/record.url?scp=20044392019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044392019&partnerID=8YFLogxK

U2 - 10.1002/ajh.20363

DO - 10.1002/ajh.20363

M3 - Review article

C2 - 15929102

AN - SCOPUS:20044392019

SN - 0361-8609

VL - 79

SP - 147

EP - 157

JO - American journal of hematology

JF - American journal of hematology

IS - 2

ER -

Waldenström macroglobulinemia: A review of therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this